Seeking Alpha

More on Rosetta Stone's Q2: No explanation is given for the poor results. However, the company...

More on Rosetta Stone's Q2: No explanation is given for the poor results. However, the company notes international consumer sales fell 33% Y/Y to $8.1M, worse than Q1's 14% drop, and U.S. consumer swung from a 52% Q1 increase to a 4% decline. Institutional sales fell 2%, nearly even with Q1. Rosetta is expanding its 2012 adjusted EBITDA guidance range to the downside, but is leaving its revenue guidance unchanged. The Street appears skeptical. RST -23.8% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs